BUTERA, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 509
EU - Europa 395
AS - Asia 170
AF - Africa 3
SA - Sud America 1
Totale 1.078
Nazione #
US - Stati Uniti d'America 504
CN - Cina 133
GB - Regno Unito 102
IT - Italia 97
FR - Francia 47
IE - Irlanda 44
SE - Svezia 44
DE - Germania 32
VN - Vietnam 19
UA - Ucraina 10
FI - Finlandia 8
ES - Italia 6
CA - Canada 5
KR - Corea 5
TR - Turchia 5
IR - Iran 4
ZA - Sudafrica 3
IN - India 2
NO - Norvegia 2
RU - Federazione Russa 2
CO - Colombia 1
HK - Hong Kong 1
MY - Malesia 1
NL - Olanda 1
Totale 1.078
Città #
Chandler 144
Southend 95
Dublin 42
New York 41
Verona 41
Woodbridge 35
Jacksonville 33
Beijing 31
Ann Arbor 23
Ashburn 18
Lawrence 18
Princeton 18
Wilmington 15
Jinan 14
Hebei 12
Houston 12
Redmond 12
Dong Ket 11
Nanjing 11
Shenyang 10
Zhengzhou 10
Sindelfingen 7
Nanchang 6
Tianjin 6
Caserta 5
Seoul 5
Cagliari 4
Toronto 4
Haikou 3
Madrid 3
Milan 3
Pretoria 3
Redwood City 3
Seattle 3
Ardabil 2
Carate Brianza 2
Changsha 2
Chicago 2
Clearwater 2
Esslingen am Neckar 2
Fuzhou 2
Jiaxing 2
Lanzhou 2
Monmouth Junction 2
Mumbai 2
Ningbo 2
Norwalk 2
Nürnberg 2
Pordenone 2
Taizhou 2
Washington 2
Barcelona 1
Central District 1
Evanston 1
Falkenstein 1
Groningen 1
Hangzhou 1
Helsinki 1
Henderson 1
Irving 1
Kashan 1
Kemerovo 1
Leawood 1
London 1
Mcallen 1
Meda 1
Medellín 1
Minot 1
Mountain View 1
Nagold 1
Oslo 1
Pozza 1
Rome 1
Roverbella 1
San Francisco 1
Sanayi 1
Taiyuan 1
Winnipeg 1
Zanjan 1
Totale 763
Nome #
Mutant p53-dependent alterations of cancer metabolism and tumor microenvironment in pancreatic adenocarcinoma cells 87
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 84
The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition 83
The antioxidant mitochondrial protein UCP2 promotes cancer development connecting theWarburg effect and autophagy 74
UCP2 inhibition induces ROS/Akt/mTOR axis: role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism 73
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: involvement in cancer invasion and metastasis 69
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 68
Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells 64
A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin 63
Molecular interplay between mutant p53 proteins and autophagy in cancer cells 62
Oncometabolites in cancer aggressiveness and tumour repopulation 62
Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders 57
Autocrine mechanisms of cancer chemoresistance 55
Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC 46
The mutant p53-driven secretome has oncogenic functions in pancreatic ductal adenocarcinoma cells 45
Proteomic Signature of PDAC Cells with Mutant p53 44
Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity 40
Redox sensitive cysteine residues as crucial regulators of wild-type and mutant p53 isoforms 38
Totale 1.114
Categoria #
all - tutte 3.893
article - articoli 3.429
book - libri 0
conference - conferenze 258
curatela - curatele 0
other - altro 206
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 7 2
2019/2020130 15 7 0 1 17 7 17 5 2 28 9 22
2020/2021127 19 13 3 20 12 12 3 4 4 1 16 20
2021/2022140 17 35 2 6 2 7 3 19 2 5 12 30
2022/2023359 20 49 21 67 35 84 2 21 41 1 14 4
2023/2024130 6 3 13 12 18 47 3 16 1 11 0 0
Totale 1.114